Sperm Parameters Before and After COVID-19 mRNA Vaccination
Daniel González, Daniel E. Nassau, Kajal Khodamoradi, Emad Ibrahim, Rubén Blachman-Braun, Jesse Ory, Ranjith Ramasamy
Abstract
Two mRNA vaccines, BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna), received Emergency Use Authorization from the US Food and Drug Administration. Despite high efficacy and few adverse
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)SpermVaccinationFertility2019-20 coronavirus outbreakAndrologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Messenger RNAVirologyInternal medicineEnvironmental healthGeneticsGeneOutbreakInfectious disease (medical specialty)PopulationBiologyDiseaseCOVID-19 Impact on ReproductionVaccine Coverage and HesitancyReproductive System and Pregnancy